3 years, 3 months ago

A new injection to prevent HIV, rather than pills, is a game changer, scientists say

A new injection to prevent HIV, rather than pills, is a game changer, scientists say Enlarge this image toggle caption ViiV Healthcare ViiV Healthcare A long-awaited development to help stop the spread of HIV and AIDS was approved by the U.S. Food and Drug Administration this week, and scientists are calling it a game-changer. The drug, called Apretude but also known as cabotegravir, is an injection that has proven to be significantly more effective at reducing the risk of sexually-acquired HIV. Sponsor Message "This new medication, cabotegravir, is a game changer," Kenneth Mayer, medical research director at Fenway Health in Boston, one of the sites where it was tested in clinical trials, told NPR. "This injection, given every two months, will be critical to addressing the HIV epidemic in the U.S., including helping high-risk individuals and certain groups where adherence to daily medication has been a major challenge or not a realistic option," Dr. Debra Birnkrant, director of the Division of Antivirals at the FDA, said in a statement.

NPR

Discover Related